Tonix Pharmaceuticals, Inc.

219 articles with Tonix Pharmaceuticals, Inc.

• TONIX Pharmaceuticals, Inc. to Present at Marcum MicroCap Conference

  6/19/2012

• TONIX Pharmaceuticals, Inc. Featured on GLX-TV OpenCEOLive Series

  6/14/2012

• TONIX Pharmaceuticals, Inc. CEO Interviewed on CEOLive.TV

  5/23/2012

• TONIX Pharmaceuticals, Inc. Appoints Dr. Samuel Saks to Its Board of Directors

  5/10/2012

• TONIX Pharmaceuticals, Inc. to Present at Three Investor Conferences in May

  4/30/2012

• TONIX Pharmaceuticals, Inc. Completes Pharmacokinetic Study on New Formulation of TNX-102 for Fibromyalgia

  4/6/2012

• TONIX Pharmaceuticals, Inc. Strengthens Management Team With the Appointments of Its New Chief Financial Officer and Senior Director of Drug Development

  4/4/2012

• TONIX Pharmaceuticals, Inc. Holding Corp. Closes on Net Proceeds of $2.0 Million in Second Tranche of a $6.6 Million Private Placement

  3/6/2012

• TONIX Pharmaceuticals, Inc. to Present at the 14th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference on February 14, 2012

  2/7/2012

• TONIX Pharmaceuticals, Inc. Closes $4.3 Million Private Placement

  1/23/2012

• TONIX Pharmaceuticals, Inc. to Present at Biotech Showcase and OneMedForum Conferences in San Francisco on January 9 and 10, 2012

  1/4/2012

• TONIX Pharmaceuticals, Inc. to Present at the New York Society of Security Analysts' 15th Annual Biotech and Specialty Pharmaceuticals Conference on November 30, 2011

  11/21/2011

• TONIX Pharmaceuticals, Inc. Receives FDA Clearance to Initiate a Pharmacokinetic Study of TNX-102 for Fibromyalgia

  11/18/2011

• TONIX Pharmaceuticals, Inc. and Tamandare Explorations Announce Completion of Share Exchange Transaction and Private Placement

  10/14/2011

• TONIX Pharmaceuticals, Inc.' Bedtime Very Low Dose Cyclobenzaprine Study Featured in Journal of Rheumatology

  9/7/2011

• TONIX Pharmaceuticals, Inc. Elects Charles Mather to Its Board of Directors

  8/17/2011

• TONIX Pharmaceuticals, Inc. Elects Harvey Moldofsky, M.D., to Its Scientific Advisory Board

  6/20/2011

• TONIX Pharmaceuticals, Inc. Presents Findings on the Effects of Bedtime Very Low Dose (VLD) Cyclobenzaprine (CBP) on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome

  6/16/2011

• TONIX Pharmaceuticals, Inc. to Present at the OneMedForum San Francisco 2011 on January 11 and at the Biotech Showcase on January 12

  1/4/2011